Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
Recruiting now
Conditions studied: Thoracic Tumors
In brief
To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
Key facts
- Study ID
- NCT06840288
- Run by
- M.D. Anderson Cancer Center
- People needed
- 250
- Starts
- 2025-02-19
- Expected to finish
- 2036-12-31
- Last updated by the study team
- 2026-06-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with peripheral lung tumors (primary or metastatic) that have been or will be ablated via robotic bronchoscopy.
You may not qualify if…
- Patients with planned bronchoscopic ablations of peripheral lung tumors that were aborted for technical reasons (ablation was not completed).
Where it is running
- MD Anderson Cancer Center — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.